FDA Inspection
Haemonetics Manufacturing, Inc.Haemonetics Manufacturing, Inc. – FDA Inspection, Sep 25, 2019
Record Details
This FDA Inspection record concerns Haemonetics Manufacturing, Inc., with an inspection on September 25, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 23fe902d-0089-4a33-9287-f2c002880213
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1109177
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Haemonetics Manufacturing, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 1, 2026 | Not classified | Los Angeles District Office | Blood and Blood Products |
| September 22, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 27, 2018 | Not classified | Los Angeles District Office | |
| May 15, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 19, 2014 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Haemonetics Manufacturing, Inc.
- FDA Inspection 1314924 - 2026-05-01
- FDA Inspection 1219069 - 2023-09-22
- FDA Inspection 1128913 - 2018-09-27
- FDA Inspection 1053259 - 2018-05-15
- FDA Inspection 891996 - 2014-08-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.